Back to top

Facing unprecedented threats against HIV prevention, it’s vital that PrEP users speak out and mobilize, says Michael Chancley, MSW, as he introduces this series of commentaries by PrEP users and advocates

I learned about PrEP early on in my career in HIV advocacy, just as the Centers for Disease Control and Prevention (CDC) released the first clinical guidelines for prescribers in 2014. I made the decision to become a PrEP user early the next year. As someone fairly new to advocacy work, I was naïve and believed that ending new HIV transmissions was within reach. We had a revolutionary new drug (Truvada being the only FDA-approved formulation of PrEP at the time), so we just had to get it into the hands of people most vulnerable to HIV.

Of course, the reality of stigma, provider misinformation and biases, lack of public education and healthcare coverage barriers slowly became apparent to me, not only as an advocate helping others access PrEP, but also for myself as a PrEP user.   

Most recent estimates from the CDC show that 2.2 million could benefit from PrEP, yet 31,000 acquire HIV in the United States annually. With PrEP being FDA-approved for over 13 years now and new modalities becoming available, the broken systems of healthcare and HIV prevention are failing to get PrEP to those who could benefit the most. 

PrEP users who are knowledgeable both in the barriers they face and the potential policy solutions to promote access are uniquely valuable warriors in the battle for HIV prevention equity. With media, policymakers and coalitions, I have seen how my ability to translate the personal into the political can change hearts and minds, quiet opposition and inspire champions. 

For this reason, I am so pleased to collaborate with POSITIVELY AWARE to present a special series on PrEP access, driven by authors who are themselves PrEP users. I invite you to read through their perspectives and, if so inspired, log on to PrEP4All.org to see how you can join our PrEP Users’ Union.

Barriers to PrEP access 

My first time experiencing barriers to PrEP access, and having to advocate for myself, was in 2015. Despite PrEP having been around for three years, my provider had never heard of using Truvada for HIV prevention. Gratefully, she was willing to listen as I explained why as a gay male, I needed an HIV prevention method beyond just condoms. I emailed her the CDC guidelines on PrEP, and she did her due diligence of reviewing the potential side effects, efficacy and necessary labs needed to prescribe PrEP. 

I then found myself left with a copay of $300 per 30-day supply of PrEP medication and copays associated with labs. Luckily, as an advocate, I was aware of manufacturer copay assistance programs for medication, and I could afford the lab copays. 

Even with increased education and awareness and advocacy to reduce cost barriers, lack of access to knowledgeable providers as well as inadequate insurance coverage and the high cost of long-acting injectables continue to be barriers to uptake. 

Both ViiV Healthcare and Gilead Sciences manufacture forms of long-acting injectable PrEP—Apretude and Yeztugo, each priced at $23,500 and $28,000 per person per year respectively. These costs are so high, CVS Health, one of the largest pharmacy benefits managers in the U.S., only started covering Yeztugo—which was FDA approved last summer—this year. 

Insured PrEP users saw some relief when the U.S. Preventive Services Task Force (USPSTF) gave PrEP a Grade A rating. Under the Affordable Care Act (often referred to as “Obamacare”), PrEP must be provided at no cost to consumers who have ACA-compliant insurance plans.

The ACA has been under constant attack since its inception and now threats to the USPSTF—specifically from Robert F. Kennedy, Jr.’s Department of Health and Human Services—imperil PrEP access as well. 

Even with bipartisan promises to end the HIV epidemic by 2030, and PrEP being recognized as a necessary tool to end the epidemic, unprecedented threats to HIV funding and infrastructure could dismantle research, workforce and community-based programs necessary to ensure PrEP access. 

PrEP users fight back in unprecedented times 

Advocacy to end the HIV epidemic could not be effective without meaningful involvement of people living with HIV/AIDS (MIPA). Lived experience guides advocacy through stigma, education, awareness and systemic barriers. Following the same principles, advocacy toward PrEP access must include the voices and experiences of current and former PrEP users.

I am grateful to have the perspectives of Joseph Cherabie, MD, MSc, PrEP user and board member of the HIV Medicine Association (HIVMA), and Julia C. Rosebush, DO, FAAP, FPIDS, and HIVMA board member, who walk us through how current political threats such as cuts to HIV funding, attacks on marginalized groups and gutting of the CDC will create further barriers to PrEP access. Similarly, John Meade, Jr., MPH, of AVAC, discusses how efforts to dismantle PEPFAR are devastating global access to care, treatment and prevention services. 

In my HIV advocacy, I have navigated clients through HIV prevention and treatment services. I quickly learned that navigating prevention and treatment each have their own similar, but unique challenges. As an HIV prevention policy advocate, it is important that PrEP users speak to the unique challenges towards PrEP access. 

Advocacy for PrEP access must include the voices and experiences of current and former PrEP users.

PrEP4All has always centered the voices of PrEP users since its founding in 2018. In 2023, PrEP4All further elevated the voices of PrEP users with the launch of the PrEP Users’ Union. 

The PrEP Users’ Union has created campaigns such as the #PrEPSaves and PrEP Advocates Unleashed, highlighting calls for a federally-funded National PrEP Program for uninsured and underinsured individuals. Additionally, PrEP users have had opportunities to discuss the need for PrEP access with congressional leaders and engage with the news media on issues such as Kennedy v. Braidwood (the PrEP access case heard by the Supreme Court last year). 

The HIV movement is currently seeing unprecedented attacks, many of which will directly impact access to PrEP. In this moment in history, it is vital that PrEP users speak out and mobilize against price gouging of long-acting injectable PrEP, funding threats to HIV prevention and care and the dismantling of HIV prevention infrastructure.

I hope you enjoy these commentaries by PrEP users and become inspired to get involved, and that you will share your own perspectives on how the personal is political. Please contact me at michael@PrEP4All.org to learn more. 

MICHAEL CHANCLEY, MSW, is a social worker, educator, writer, HIV advocate and PrEP user who has developed and implemented community-based and national HIV prevention programs for communities disproportionately impacted by HIV. 

He currently serves as the communications and mobilization manager of PrEP4All and is a co-founding member of PrEP In Black America (PIBA). He also serves as a Greater Than HIV ambassador.